2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one has been researched along with Cancer-Associated Pain in 2 studies
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one: specific inhibitor of phosphatidylinositol 3-kinase; structure in first source
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhao, J | 1 |
| Yan, Y | 2 |
| Zhen, S | 1 |
| Yu, L | 1 |
| Ding, J | 1 |
| Tang, Q | 1 |
| Liu, L | 1 |
| Zhu, H | 1 |
| Xie, M | 1 |
| Liang, Y | 1 |
| Ding, T | 1 |
| Chu, H | 1 |
2 other studies available for 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Cancer-Associated Pain
| Article | Year |
|---|---|
LY294002 alleviates bone cancer pain by reducing mitochondrial dysfunction and the inflammatory response.
Topics: Animals; Bone Neoplasms; Cancer Pain; Disabled Persons; Humans; Mitochondria; Motor Disorders; Neura | 2023 |
PI3K/Akt signaling pathway may be involved in MCP-1-induced P2X4R expression in cultured microglia and cancer-induced bone pain rats.
Topics: Animals; Benzoxazines; Calcium-Binding Proteins; Cancer Pain; Cell Line, Tumor; Chemokine CCL2; Chro | 2019 |